GDF15 and Anorexia: Both hepatic IRE1α knockout and IRE1α ribonuclease inhibitors markedly attenuate liver Gdf15 production and reduce circulating GDF15 concentrations, leading to improved chemotherapy-associated anorexia and body mass reduction [173].